| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer
1 company
Christopher Sarchi is Chief Commercial Officer at REPL. Christopher Sarchi's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $3.7M at current prices.
Our model assigns Christopher Sarchi a middling insider score of 55/100, based on 8 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of +10.3%.
The REPL filings lean toward selling, a net 48,763 shares.
Christopher Sarchi has 12 Form 4 filings on record from November 2023 to June 2026, all as Chief Commercial Officer at Replimune Group (REPL), 2023–2026.
The 15 reported transactions were 8 open-market sales, 4 stock awards and 3 option or other derivative awards.
Counted by filing, the open-market trades come to no purchases and 8 sales worth about $412K.
The largest open-market sale was 12,000 shares of REPL at an average $9.24 on June 1, 2026, about $111K.
2 of the 8 sales since April 2023 were made under a Rule 10b5-1 trading plan; the other 6 were not.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | REPL Replimune Group, Inc. | Chief Commercial Officer | Sell10b5-1 | 12,000 | $9.24 | $110,880.00 | -6.2% | +70.0% | - | |
| May 18, 2026 | REPL Replimune Group, Inc. | Chief Commercial Officer | Sell | 8,626 | $5.08 | $43,820.08 | -4.3% | +192.0% | - | |
| Apr 2, 2026 | REPL Replimune Group, Inc. | Chief Commercial Officer | Sell10b5-1 | 6,500 | $8.01 | $52,065.00 | -4.1% | +33.4% | - | |
| Nov 17, 2025 | REPL Replimune Group, Inc. | Chief Commercial Officer | Sell | 5,208 | $9.10 | $47,392.80 | -4.1% | -17.2% | - | |
| May 20, 2025 | REPL Replimune Group, Inc. | Chief Commercial Officer | Sell | 3,749 | $8.05 | $30,179.45 | -2.8% | -42.0% | -43.9% | |
| Nov 18, 2024 | REPL Replimune Group, Inc. | Chief Commercial Officer | Sell | 5,207 | $10.78 | $56,131.46 | -5.6% | +30.3% | -18.8% | |
| May 16, 2024 | REPL Replimune Group, Inc. | Chief Commercial Officer | Sell | 2,218 | $6.47 | $14,350.46 | -2.3% | +46.7% | +16.8% | |
| Nov 16, 2023 | REPL Replimune Group, Inc. | Chief Commercial Officer | Sell | 5,255 | $10.92 | $57,384.60 | -6.8% | -33.4% | +4.7% |